CONTEXT: The majority of patients presenting with short stature do not receive a definitive diagnosis. Advances in genetic sequencing allow for large-scale screening of candidate genes, potentially leading to genetic diagnoses. OBJECTIVES: The purpose of this study was to discover genetic variants that contribute to short stature in a cohort of children with no known genetic etiology. DESIGN: This was a prospective cohort study of subjects with short stature. SETTING: The setting was a pediatric endocrinology and genetics clinics at an academic center. PATIENTS: A total of 192 children with short stature with no defined genetic etiology and 192 individuals of normal stature from the Framingham Heart Study were studied. INTERVENTION: Pooled targeted sequencing using next-generation DNA sequencing technology of the exons of 1077 candidate genes was performed. MAIN OUTCOME MEASURES: The numbers of rare nonsynonymous genetic variants found in case patients but not in control subjects, known pathogenic variants in case patients, and potentially pathogenic variants in IGF1R were determined. RESULTS: We identified 4928 genetic variants in 1077 genes that were present in case patients but not in control subjects. Of those, 1349 variants were novel (898 nonsynonymous). False-positive rates from pooled sequencing were 4% to 5%, and the false-negative rate was 0.1% in regions covered well by sequencing. We identified 3 individuals with known pathogenic variants in PTPN11 causing undiagnosed Noonan syndrome. There were 9 rare potentially nonsynonymous variants in IGF1R, one of which is a novel, probably pathogenic, frameshift mutation. A previously reported pathogenic variant in IGF1R was present in a control subject. CONCLUSIONS: Large-scale sequencing efforts have the potential to rapidly identify genetic etiologies of short stature, but data interpretation is complex. Noonan syndrome may be an underdiagnosed cause of short stature.
CONTEXT: The majority of patients presenting with short stature do not receive a definitive diagnosis. Advances in genetic sequencing allow for large-scale screening of candidate genes, potentially leading to genetic diagnoses. OBJECTIVES: The purpose of this study was to discover genetic variants that contribute to short stature in a cohort of children with no known genetic etiology. DESIGN: This was a prospective cohort study of subjects with short stature. SETTING: The setting was a pediatric endocrinology and genetics clinics at an academic center. PATIENTS: A total of 192 children with short stature with no defined genetic etiology and 192 individuals of normal stature from the Framingham Heart Study were studied. INTERVENTION: Pooled targeted sequencing using next-generation DNA sequencing technology of the exons of 1077 candidate genes was performed. MAIN OUTCOME MEASURES: The numbers of rare nonsynonymous genetic variants found in case patients but not in control subjects, known pathogenic variants in case patients, and potentially pathogenic variants in IGF1R were determined. RESULTS: We identified 4928 genetic variants in 1077 genes that were present in case patients but not in control subjects. Of those, 1349 variants were novel (898 nonsynonymous). False-positive rates from pooled sequencing were 4% to 5%, and the false-negative rate was 0.1% in regions covered well by sequencing. We identified 3 individuals with known pathogenic variants in PTPN11 causing undiagnosed Noonan syndrome. There were 9 rare potentially nonsynonymous variants in IGF1R, one of which is a novel, probably pathogenic, frameshift mutation. A previously reported pathogenic variant in IGF1R was present in a control subject. CONCLUSIONS: Large-scale sequencing efforts have the potential to rapidly identify genetic etiologies of short stature, but data interpretation is complex. Noonan syndrome may be an underdiagnosed cause of short stature.
Authors: M J E Walenkamp; H J van der Kamp; A M Pereira; S G Kant; H A van Duyvenvoorde; M F Kruithof; M H Breuning; J A Romijn; M Karperien; J M Wit Journal: J Clin Endocrinol Metab Date: 2006-06-06 Impact factor: 5.958
Authors: Alvina R Kansra; Lawrence M Dolan; Lisa J Martin; Ranjan Deka; Steven D Chernausek Journal: Eur J Endocrinol Date: 2012-09-12 Impact factor: 6.664
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb Journal: Nat Genet Date: 2001-12 Impact factor: 38.330
Authors: M Jennifer Abuzzahab; Anke Schneider; Audrey Goddard; Florin Grigorescu; Corinne Lautier; Eberhard Keller; Wieland Kiess; Jürgen Klammt; Jürgen Kratzsch; Doreen Osgood; Roland Pfäffle; Klemens Raile; Berthold Seidel; Robert J Smith; Steven D Chernausek Journal: N Engl J Med Date: 2003-12-04 Impact factor: 91.245
Authors: Matthew J Rock; Jean Prenen; Vincent A Funari; Tara L Funari; Barry Merriman; Stanley F Nelson; Ralph S Lachman; William R Wilcox; Soraya Reyno; Roberto Quadrelli; Alicia Vaglio; Grzegorz Owsianik; Annelies Janssens; Thomas Voets; Shiro Ikegawa; Toshiro Nagai; David L Rimoin; Bernd Nilius; Daniel H Cohn Journal: Nat Genet Date: 2008-06-29 Impact factor: 38.330
Authors: David L Rimoin; Daniel Cohn; Deborah Krakow; William Wilcox; Ralph S Lachman; Yasemin Alanay Journal: Ann N Y Acad Sci Date: 2007-11 Impact factor: 5.691
Authors: Ola Nilsson; Michael H Guo; Nancy Dunbar; Jadranka Popovic; Daniel Flynn; Christina Jacobsen; Julian C Lui; Joel N Hirschhorn; Jeffrey Baron; Andrew Dauber Journal: J Clin Endocrinol Metab Date: 2014-04-24 Impact factor: 5.958
Authors: Helen L Storr; Sumana Chatterjee; Louise A Metherell; Corinne Foley; Ron G Rosenfeld; Philippe F Backeljauw; Andrew Dauber; Martin O Savage; Vivian Hwa Journal: Endocr Rev Date: 2019-04-01 Impact factor: 19.871
Authors: Jeffrey Baron; Lars Sävendahl; Francesco De Luca; Andrew Dauber; Moshe Phillip; Jan M Wit; Ola Nilsson Journal: Nat Rev Endocrinol Date: 2015-10-06 Impact factor: 43.330
Authors: Daniel C Koboldt; Karyn Meltz Steinberg; David E Larson; Richard K Wilson; Elaine R Mardis Journal: Cell Date: 2013-09-26 Impact factor: 41.582
Authors: Sophie R Wang; Christina M Jacobsen; Heather Carmichael; Aaron B Edmund; Jerid W Robinson; Robert C Olney; Timothy C Miller; Jennifer E Moon; Veronica Mericq; Lincoln R Potter; Matthew L Warman; Joel N Hirschhorn; Andrew Dauber Journal: Hum Mutat Date: 2015-03-16 Impact factor: 4.878
Authors: Melanie R Shapiro; Timothy P Foster; Daniel J Perry; Ron G Rosenfeld; Andrew Dauber; James A McNichols; Andrew Muir; Vivian Hwa; Todd M Brusko; Laura M Jacobsen Journal: Horm Res Paediatr Date: 2020-10-28 Impact factor: 2.852
Authors: Michael H Guo; Yiping Shen; Emily C Walvoord; Timothy C Miller; Jennifer E Moon; Joel N Hirschhorn; Andrew Dauber Journal: Horm Res Paediatr Date: 2014-06-20 Impact factor: 2.852